Coagulation system activity before coronary artery bypass surgery for unstable angina

Scandinavian Cardiovascular Journal

Volumn 35, Issue 4, 2001, Pages 280-284

  Bjessmo, Staffan ^a   Ivert, Torbjörn ^a   Egberg, Nils ^a,b  

^a Department of Thoracic Surgery ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coagulation; Coronary artery bypass surgery; Unstable angina

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BETA THROMBOGLOBULIN; D DIMER; DALTEPARIN; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ELECTIVE SURGERY; FEMALE; FIBRINOLYSIS; GRAFT FAILURE; HUMAN; HYPERCOAGULABILITY; MALE; PATIENT CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REST; RISK ASSESSMENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ANTITHROMBIN III; ANTITHROMBINS; BETA-THROMBOGLOBULIN; BLOOD COAGULATION; CORONARY ARTERY BYPASS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROTHROMBIN;

EID: 0034775479     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430152581404     Document Type: Article

References (22)

1. Merlini PA, Bauer KA, Oltrona L. et al. Persistent activation ot' coagulation mechanism in unstable angina and myocardial infarction. C'ireuhnion 1994; 90; 61-68.
2. Anlissino D. Merlini PA. (ianiha G. et al. Thrombin activity and early outcome in unstable angina pectoris. Circulation 1996: 93: 1634- 1659.
3. Hiasiieei LM. Liuuzzo G, Caligiuri Ci, cl al. Temporal relation between isehemie episodes and aetiation of Ihe coagulation system in unstable an-jina. Circulation 1996:93: 2121-2127.
4. Hoffmeistei HM. Jur M. Wendel HP. Heller W. Seipel I.. Alterations of coagulation and tihrinolytic ami kallikrein-kinin systems in Ihe acute and postaciile phases in patients with unstable angina peetoris. Circulation 1945: 91 : 2520-2527.
5. Turpie A(i. l.ow-molocular-weighl heparins in acute unstable coronary artery disease-an update. Haemostasis 1999: 29 Suppl SI: 72-75.
6. Bramnvald F. L'nstable angina. A classification. Circulation 1989: 80: 410-414.
7. Odegard OR. Lie M. Abildgaard U. Heparin cofactor activity measured with an amidolytic meihod. Thromb Res 1975: 6: 287-294.
8. Pel/er H. Schwur/ A. Hcimburger N. Determination of human Ihrombinanlithromhin III complex in plasma with an enJ.yme-linked immunosorbem assay. Throinb Haemosl 1988: 59: 101-106.
9. Teitel JM. Bauer KA. Lau HK. Rosenberg RD. Studies of the prothrombin activation pathway ulili/ing radioimmunoassays for the F2/FI 2 fragment and thrombiil-aritithrombin complex. Blood 1982:59: 1086-1097.
10. Elms MJ. Bunco IH. Bundesen PG. el al. Measurement of crosslinked tihrin degradation product:-an immunoassay using monoclonal antibodies. Thromb Haemost 19X3; 50: 591-594.
11. Wiman B. Chmielewska J. Ranby M. Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. J Biol Chem 1984: 259: 3644-3647.
12. Ludlam C A. Moore S. Bolton AE. Pepper DS. Cash JD. The release of a human platelet specific protein measured by LI radioimnumoassay. Thromh Res [975: 6: 543-548.
13. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRLSC II prospective randomised mullieemre study. FRagmin and Fast Revascularisalion during Instability in Coronary artery disease Investigators. Lancet 1999: 354: 70X-715.
14. Prisco D. Markers of increased thrombin generation jeditoriall. Rie Clin Lab 1990; 20: 217-225.
15. Biasucci LM. Liu//o G. Angiolillo DJ. Sperti G. Maseri A. Inflammation and acute coronary syndromes. Her/ 2000; 25: 108-112.
16. Thompson SG. Fechtrup C. Squire E. et al. AiHilhrombin III and fibrinogcn as predictors of cardiac events in patients with angina peetoris. Arterioscler Thromb Vase Biol 1996: 16: 357-362.
17. Herren T. Stricker H. Haeberli A. Do DD. Sträub PW. Fibrin formation and degradation in patients with arterioselerotic disease. Circulation 1994; 90: 2679-2686.
18. Hamsten A. de Faire U. Walldius G. et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardia! infarction. Lancet 1987; 2: 3-9.
19. WiecJ.orek I. Ludlam CA. Fox KA. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina. Am J Cardiol 1994; 74: 424-429.
20. Zajtchuk R, Collins GJ. Holley PW. Heydron WH, Schuehmann GF. Hamaker WR. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts. J Thorac Cardiovase Surg 1977; 73: 309-311.
21. Arnesen H. Semb G. Hol R. Karlsen H. Fibrinolytie capacity after venous stasis in patients undergoing aorto-coronary by-pass surgery. Relation to shunt occlusion. Scancl J Haematol 1983; 30: 43-46.
22. Moor E. Blomback M. Silveira A. et al. Haemostatic function in patients undergoing coronary artery bypass grafting: Perioperative perturbations and relations to saphenous vein graft closure. Thromb Res 2000: 98: 39-49.